MedPath

Potassium

Generic Name
Potassium
Drug Type
Small Molecule
Chemical Formula
K
CAS Number
7440-09-7
Unique Ingredient Identifier
RWP5GA015D
Background

Potassium is an essential nutrient, like Calcium and Magnesium. It was identified as a shortfall nutrient by the 2015-2020 Advisory Committee of Dietary Guidelines for Americans. Many conditions and diseases interfere with normal body potassium balance, and underconsumption of potassium is one example. Hypokalemia (low potassium) or hyperkalemia (high potassium) may result, manifesting as various signs and symptoms. Some examples of potassium-related complications include life-threatening arrhythmia, neuromuscular dysfunction, diarrhea, nausea, and vomiting.

Various pharmacological preparations have been formulated to replenish potassium. They are available in an assortment of tablet, injection, and other forms, depending on the setting and condition being treated. Potassium is often a key ingredient for intravenous fluids, given to patients in clinical settings for rehydration, nutrition, and replenishment of electrolytes. Examples of potassium formulations include potassium citrate, potassium chloride, and potassium with dextrose and sodium chloride.

Indication

General uses of potassium

Potassium is indicated to treat a variety of conditions. Firstly, it used to replenish potassium that has been depleted by conditions including but not limited to malabsorption, decreased intake, or excess sodium intake. The causes of potassium deficiency are numerous. The following indications for potassium are not comprehensive, but include the main indications for which this nutrient is used. Various products and preparations contain potassium.

Potassium chloride

Potassium chloride is one of the main preparations of potassium used in a clinical setting. The oral solution is indicated for the prevention and treatment of hypokalemia presenting with or without metabolic alkalosis, in patients who have failed conservative management with potassium-rich foods or diuretic dose titrations. The injection form of potassium chloride is indicated to replenish potassium in patients who are not feasible candidates for oral potassium. Highly concentrated potassium is intended for the treatment of potassium deficiency in fluid restricted individuals who cannot tolerate fluid volumes normally associated with injected potassium solutions that contain lower concentrations.

Finally, the extended-release tablet preparation of potassium chloride is used to treat hypokalemia with or without metabolic alkalosis, to treat digitalis intoxication, and to manage patients with hypokalemic familial periodic paralysis. It is also used in the prevention of hypokalemia in those who are at a high risk of negative clinical outcomes if hypokalemia occurs; patients on digitalis or those with cardiac arrhythmias would be at particular risk of negative outcomes.

Potassium chloride with dextrose and sodium chloride

This liquid preparation is is indicated in a clinical setting as a source of water, calories and electrolytes. Potassium acetate solution is meant as an alternative to potassium chloride, replenishing potassium and added to large volume infusion fluids for intravenous injection.

Potassium citrate

The potassium citrate preparation is used for the management of renal tubular acidosis (RTA) with calcium stones (nephrolithiasis); calcium oxalate stones by any cause, and uric acid nephrolithiasis (with or without calcium stones). This regimen also includes adequate water intake (leading to a urine out put of 2 L/day or more) and sodium restriction.

Associated Conditions
Caloric Intake, Electrolyte and fluid balance conditions, Hydration, Hypokalemia, Potassium

Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

Recruiting
Conditions
Arterial Thrombosis
Antiphospholipid Syndrome
First Posted Date
2022-12-12
Last Posted Date
2022-12-14
Lead Sponsor
McMaster University
Target Recruit Count
150
Registration Number
NCT05646394
Locations
🇨🇦

McMaster University, Hamilton, Ontario, Canada

🇦🇷

Instituto de Investigaciones en Salud Pública, Universidad de Buenos Aires, Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina

🇦🇷

Clinica Universitaria Reina Fabiola, Córdoba, Argentina

Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension

Phase 4
Recruiting
Conditions
Hypertension
Left Ventricular Hypertrophy
Interventions
First Posted Date
2022-10-25
Last Posted Date
2024-12-16
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
75
Registration Number
NCT05593055
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses

First Posted Date
2022-06-24
Last Posted Date
2024-03-27
Lead Sponsor
Shandong University
Target Recruit Count
406
Registration Number
NCT05431075
Locations
🇨🇳

Zhengzhou Central Hospital, Zhengzhou, Henan, China

🇨🇳

Qilu hosipital, Jinan, Shandong, China

🇨🇳

Taierzhuang District People's Hospital, Taierzhuang, Shandong, China

and more 3 locations

Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment

Phase 4
Completed
Conditions
Acute Heart Failure
Diuretics Drug Reactions
Interventions
Diagnostic Test: UNa measurement after intravenous loop diuretic bolus
Other: Usual AHF care
Other: Maintenance infusion
Other: Intravenous hypertonic saline
Other: Switch to oral diuretic therapy
First Posted Date
2022-06-09
Last Posted Date
2024-07-23
Lead Sponsor
Vrije Universiteit Brussel
Target Recruit Count
107
Registration Number
NCT05411991
Locations
🇧🇪

Jessa Hospital, Hasselt, Limburg, Belgium

🇧🇪

University Hospital Brussels, Jette, Brussels, Belgium

Potassium Citrate and Crystal Light Lemonade

Not Applicable
Recruiting
Conditions
Kidney Stone
Interventions
First Posted Date
2022-05-25
Last Posted Date
2025-04-27
Lead Sponsor
Northwestern University
Target Recruit Count
10
Registration Number
NCT05389995
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment

First Posted Date
2022-02-22
Last Posted Date
2022-03-18
Lead Sponsor
Shanghai Zhongshan Hospital
Target Recruit Count
388
Registration Number
NCT05250050
Locations
🇨🇳

Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, Shanghai, China

🇨🇳

Huashan Hospital, Fudan University, Shanghai, Shanghai, China

🇨🇳

Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China

The Evaluation of Triple Therapy With Vonoprazan, Amoxicillin and Bismuth for Eradication of Helicobacter Pylori

First Posted Date
2022-01-12
Last Posted Date
2022-03-22
Lead Sponsor
Huazhong University of Science and Technology
Target Recruit Count
672
Registration Number
NCT05189444
Locations
🇨🇳

Tongji Hospital, Tongji Medical College, HUST, Wuhan, Hubei, China

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Completed
Conditions
Treatment of Venous Thromboembolism in Cancer Patients
Interventions
Drug: Low molecular weight heparin (LMWH)
Drug: other NOACs
First Posted Date
2021-12-09
Last Posted Date
2023-12-18
Lead Sponsor
Bayer
Target Recruit Count
5737
Registration Number
NCT05150938
Locations
🇸🇪

Swedish registries, Multiple Locations, Many Locations, Sweden

SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial

First Posted Date
2021-12-01
Last Posted Date
2025-02-19
Lead Sponsor
University of Pennsylvania
Target Recruit Count
53
Registration Number
NCT05138575
Locations
🇺🇸

University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction

Phase 2
Not yet recruiting
Conditions
Peritoneal Metastases
Stomach Neoplasms
Interventions
Procedure: HIPEC
Drug: Paclitaxel-albumin
Procedure: Surgery+HIPEC
First Posted Date
2021-10-27
Last Posted Date
2021-10-27
Lead Sponsor
Xuefei.Wang
Target Recruit Count
157
Registration Number
NCT05095467
© Copyright 2025. All Rights Reserved by MedPath